FIELD: pharmaceuticals.
SUBSTANCE: invention relates to a method for producing a fluorinated organic compound, described by the following formula (1):
in which R1 means phenyl, optionally containing halogen or C1-6 alkyl, R2 means hydrogen or C1-6 alkyl, R3 means hydrogen, L means alkanediyl, -CONR- or -CO-O-, where R in each occurrence independently is hydrogen or C1-6 alkyl, R4 is hydroxyl or C1-6 alkyl and RX is fluoro, provided that when L is -CONR- and R is hydrogen or methyl, R4 is not methyl, and that if L is -CO-O-, R4 is neither methyl nor propyl, the process comprises an alkene reaction step A of the following formula (2):
with a source of fluorine, which is the source (3a) described by the formula MFn in which M is H, a metal of group 1 of the Periodic Table of the Elements or a metal of group 2 of the Periodic Table of the Elements and n is 1 or 2, in the presence of an aromatic compound containing hypervalent iodine, or in the presence of an iodine-containing aromatic compound and an oxidant to fluorinate the alkene.
EFFECT: new method for obtaining a fluorinated organic compound which can provide a higher yield and high selectivity in obtaining the target compound.
4 cl, 41 ex
Title | Year | Author | Number |
---|---|---|---|
PYRIDONES AND AGRICULTURAL AND GARDEN FUNGICIDES CONTAINING THEM AS ACTIVE INGREDIENTS | 2018 |
|
RU2765748C2 |
METHOD FOR PRODUCING FLUORINATED ORGANIC COMPOUNDS | 2019 |
|
RU2764719C1 |
METHOD FOR PRODUCING FLUORINATED ORGANIC COMPOUNDS | 2019 |
|
RU2764581C1 |
METHOD FOR PRODUCING FLUORINE-CONTAINING ORGANIC COMPOUND | 2021 |
|
RU2807182C1 |
METHOD OF TREATMENT OF SCHIZOPHRENIA | 2012 |
|
RU2648474C2 |
COMBINED THERAPY INCLUDING SGLT INHIBITORS AND DPP4 INHIBITORS | 2009 |
|
RU2481106C2 |
2-AMINOPYRIDINE DERIVATIVES, PHARMACEUTICAL COMPOSITION CONTAINING THE SAME AND METHOD FOR THERAPY | 2001 |
|
RU2250898C2 |
HETEROCYCLIC COMPOUND | 2018 |
|
RU2791533C2 |
IMIDAZOLE COMPOUND, A METAL SURFACE TREATMENT LIQUID, A METAL SURFACE PROCESSING METHOD AND A LAMINATE MANUFACTURING METHOD | 2015 |
|
RU2692774C2 |
COMBINED APPLICATION OF PROSTAGLANDIN DERIVATIVE AND PROTON PUMP INHIBITOR FOR TREATMENT OF GASTROINTESTINAL DISEASES | 2006 |
|
RU2468800C2 |
Authors
Dates
2023-05-15—Published
2019-05-10—Filed